Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in children

Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlam, A.N.-
dc.contributor.authorAbdal, N.M.-
dc.contributor.authorWahed, M.A.-
dc.contributor.authorRao, B.-
dc.contributor.authorKawser, C.A.-
dc.contributor.authorHoque, M.-
dc.contributor.authorRahaman, M.M.-
dc.date.accessioned2008-09-07T03:27:25Z-
dc.date.available2008-09-07T03:27:25Z-
dc.date.issued1991-10-
dc.identifier.citationArch Dis Child 1991 Oct;66(10):1231-4en
dc.identifier.urihttp://hdl.handle.net/123456789/1756-
dc.description.abstractThe role of prostacyclin in the pathogenesis of haemolytic uraemic syndrome was evaluated in 11 children with acute shigellosis. Plasma concentrations of 6-keto prostaglandin, F1 alpha, a stable metabolite of prostacyclin, were measured by radioimmunoassay during acute illness, early convalescence, and after clinical recovery. Its concentration was low during acute illness in each patient, returning to normal concentrations or above at the time of the last sample. These results suggest that plasma prostacyclin may be involved in the development of the syndromeen
dc.format.extent208626 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoenen
dc.subjectHemolytic-uremic syndromeen
dc.subjectShigellaen
dc.subjectProstaglandins Xen
dc.subjectAcute diseaseen
dc.subjectDysentery, Baccillaryen
dc.subjectProstaglandins Fen
dc.subjectEpoprostenolen
dc.subjectChildrenen
dc.subjectBangladeshen
dc.titleProstacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in childrenen
dc.typeArticleen
Appears in Collections:A. Original papers

Files in This Item:
File Description SizeFormat 
1991-ArchDisChild-1231-AlamAN.pdf203.74 kBAdobe PDFView/Open    Request a copy


This item is protected by original copyright